Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative ...

The retina, as part of the central nervous system, may reflect early signs of brain disorders like schizophrenia.

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

A compelling naturopathic case study by Dr. Eric Dorninger reveals how endotoxin exposure from kitty litter led to CIRS and ...

Beth is an established commercial and strategic business executive with more than two decades of leadership experience and ...

RBC Capital lowered the firm’s price target on Apellis (APLS) to $21 from $24 and keeps a Sector Perform rating on the shares. The firm has ...

Meet the German Spitz, a friendly, trainable dog with a fluffy double coat. Explore grooming needs and health considerations.

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

Avacincaptad pegol and pegcetacoplan have similar 12-month outcomes in slowing GA, with pegcetacoplan requiring fewer injections.

Eyestem Research, a Bangalore-based cell therapy company, is pleased to announce significant vision improvement in Phase 1 trials of its investigational drug, Eyecyte-RPEtm, in patients with ...